Literature DB >> 26558186

Medical and alternative therapies in urinary tract stone disease.

Ercan Yuvanc1, Erdal Yilmaz1, Devrim Tuglu1, Ertan Batislam1.   

Abstract

Nephrolithiasis is a serious problem for both patients and the health system. Recurrence stands out as a significant problem in urinary system stone disease, the prevalence of which is increasing gradually. If recurrence is not prevented, patients may go through recurrent operations due to nephrolithiasis. While classical therapeutic options are available for all stone types, the number of randomized controlled studies and extensive meta-analyses focusing on their efficiency are inadequate. Various alternative therapeutic options to these medical therapies also stand out in recent years. The etiology of urolithiasis is multifactorial and not always related to nutritional factors. Nutrition therapy seems to be useful, either along with pharmacological therapy or as a monotherapy. General nutrition guidelines are useful in promoting public health and developing nutrition plans that reduce the risk or attenuate the effects of diseases affected by nutrition. Nutrition therapy involves the evaluation of a patient's nutritional state and intake, the diagnosis of nutrition risk factors, and the organization and application of a nutrition program. The main target is the reduction or prevention of calculus formation and growth via decreasing lithogenic risk factors and increasing lithogenic inhibitors in urine. This review focuses briefly on classical medical therapy, along with alternative options, related diets, and medical expulsive therapy.

Entities:  

Keywords:  Cysteine stones; Diet; Hypercalciuria; Hyperoxaluria; Hyperuricosuria; Hypocitraturia; Nutrition therapy; Prevention; Stone medical therapy; Urolithiasis

Year:  2015        PMID: 26558186      PMCID: PMC4635369          DOI: 10.5527/wjn.v4.i5.492

Source DB:  PubMed          Journal:  World J Nephrol        ISSN: 2220-6124


  77 in total

1.  Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life.

Authors:  Marco Dellabella; Giulio Milanese; Giovanni Muzzonigro
Journal:  Urology       Date:  2005-10       Impact factor: 2.649

Review 2.  Dietary therapy in idiopathic nephrolithiasis.

Authors:  Loris Borghi; Tiziana Meschi; Umberto Maggiore; Beatrice Prati
Journal:  Nutr Rev       Date:  2006-07       Impact factor: 7.110

3.  Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers.

Authors:  T Yasui; H Tanaka; K Fujita; M Iguchi; K Kohri
Journal:  Eur Urol       Date:  2001-05       Impact factor: 20.096

4.  A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha(1)-adrenoceptor antagonism on human ureteric activity.

Authors:  Kim Davenport; Anthony G Timoney; Francis X Keeley
Journal:  BJU Int       Date:  2006-09       Impact factor: 5.588

Review 5.  Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis.

Authors:  Sarah C Huen; David S Goldfarb
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

6.  Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis.

Authors:  M S Pearle; C G Roehrborn; C Y Pak
Journal:  J Endourol       Date:  1999-11       Impact factor: 2.942

7.  Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter.

Authors:  Sandra Sigala; Marco Dellabella; Giulio Milanese; Sara Fornari; Stefania Faccoli; Francesca Palazzolo; Angelo Peroni; Giuseppe Mirabella; Sergio Cosciani Cunico; PierFranco Spano; Giovanni Muzzonigro
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

8.  Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.

Authors:  Stacey G Koff; Edmond L Paquette; Jenny Cullen; Kevin K Gancarczyk; Paulette R Tucciarone; Noah S Schenkman
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

9.  Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.

Authors:  David W Kaufman; Judith P Kelly; Gary C Curhan; Theresa E Anderson; Stephen P Dretler; Glenn M Preminger; David R Cave
Journal:  J Am Soc Nephrol       Date:  2008-03-05       Impact factor: 10.121

10.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

View more
  1 in total

1.  Effect of Phaseolus Vulgaris on Urinary Biochemical Parameters among Patients with Kidney Stones in Saudi Arabia.

Authors:  Sahbanathul Missiriya Jalal; Abdulrahman Abdulhadi Alsultan; Hala Hazam Alotaibi; Ester Mary; Abeer Abbas Ibrahim Alabdullatif
Journal:  Nutrients       Date:  2020-10-30       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.